Cargando…

Four-year outcomes for endoscopic sleeve gastroplasty from a single centre in India

BACKGROUND: Bariatric endoscopy has emerged for non-surgical treatment of obesity, providing a treatment option for weight loss and associated comorbidities. Outcomes of endoscopic sleeve gastroplasty (ESG) of 12 months have been published by our team and there is a need for longer follow-up period...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhandari, Mahak, Kosta, Susmit, Reddy, Manoj, Mathur, Winni, Neto, Manoel Galvao, Bhandari, Mohit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034804/
https://www.ncbi.nlm.nih.gov/pubmed/36124467
http://dx.doi.org/10.4103/jmas.jmas_3_22
_version_ 1784911287251107840
author Bhandari, Mahak
Kosta, Susmit
Reddy, Manoj
Mathur, Winni
Neto, Manoel Galvao
Bhandari, Mohit
author_facet Bhandari, Mahak
Kosta, Susmit
Reddy, Manoj
Mathur, Winni
Neto, Manoel Galvao
Bhandari, Mohit
author_sort Bhandari, Mahak
collection PubMed
description BACKGROUND: Bariatric endoscopy has emerged for non-surgical treatment of obesity, providing a treatment option for weight loss and associated comorbidities. Outcomes of endoscopic sleeve gastroplasty (ESG) of 12 months have been published by our team and there is a need for longer follow-up period understanding the effects of ESG techniques. AIM: This report emphasises on weight loss pattern in follow-up time points and monitors the post-procedure improvement in comorbidities with minimum 4-year follow-up of patients undergoing ESG at a single academic centre in India. SUBJECTS AND METHODS: This was a prospective cohort study. All procedures were performed by the same surgeon. Patients with a body mass index of >30 kg/m(2) (or >27 with comorbidities) underwent ESG for treatment of obesity. Patients were systematically followed yearly after their procedure. Data collected on the primary outcome and secondary outcomes were analysed and presented. RESULTS: 612 patients (69.3% female) with a mean age of 40.70 ± 12.66 years and mean body mass index of 34.30 ± 5.05 kg/m(2) underwent ESG. Out of 612 patients, follow-up rates for a 1-2-3 and 4 years were 93.1%, 90.2%, 81.7% and 81.9%, respectively. The mean percentage total body weight loss was 18.19% (95% confidence interval [CI]: 17.72–18.57) and %EWL was 49.30% (95% CI: 48.91–49.68) with 90% of participants-maintaining a percentage of total weight loss of ≥5% and 70% of patients maintaining an EWL of ≥25% at 4 years, respectively. Resolution/improvement of comorbidities was 51.2% cases of T2DM, 65.8% cases of hypertension, 73.6% cases of dyslipidaemia and 89.9% remission were in obstructive sleep apnoea. No patient required an emergency intervention, and there was no mortality or significant morbidity. CONCLUSIONS: This study shows acceptable results with ESG at 4 years in our unit. Regular monitoring by a multidisciplinary nurtures weight loss, resolution or improvement of comorbidities and improvement of quality of life with low perioperative complications. There is a need for more reports with this approach to determine the amount and duration of weight loss outcome and medical intervention.
format Online
Article
Text
id pubmed-10034804
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-100348042023-03-24 Four-year outcomes for endoscopic sleeve gastroplasty from a single centre in India Bhandari, Mahak Kosta, Susmit Reddy, Manoj Mathur, Winni Neto, Manoel Galvao Bhandari, Mohit J Minim Access Surg Original Article BACKGROUND: Bariatric endoscopy has emerged for non-surgical treatment of obesity, providing a treatment option for weight loss and associated comorbidities. Outcomes of endoscopic sleeve gastroplasty (ESG) of 12 months have been published by our team and there is a need for longer follow-up period understanding the effects of ESG techniques. AIM: This report emphasises on weight loss pattern in follow-up time points and monitors the post-procedure improvement in comorbidities with minimum 4-year follow-up of patients undergoing ESG at a single academic centre in India. SUBJECTS AND METHODS: This was a prospective cohort study. All procedures were performed by the same surgeon. Patients with a body mass index of >30 kg/m(2) (or >27 with comorbidities) underwent ESG for treatment of obesity. Patients were systematically followed yearly after their procedure. Data collected on the primary outcome and secondary outcomes were analysed and presented. RESULTS: 612 patients (69.3% female) with a mean age of 40.70 ± 12.66 years and mean body mass index of 34.30 ± 5.05 kg/m(2) underwent ESG. Out of 612 patients, follow-up rates for a 1-2-3 and 4 years were 93.1%, 90.2%, 81.7% and 81.9%, respectively. The mean percentage total body weight loss was 18.19% (95% confidence interval [CI]: 17.72–18.57) and %EWL was 49.30% (95% CI: 48.91–49.68) with 90% of participants-maintaining a percentage of total weight loss of ≥5% and 70% of patients maintaining an EWL of ≥25% at 4 years, respectively. Resolution/improvement of comorbidities was 51.2% cases of T2DM, 65.8% cases of hypertension, 73.6% cases of dyslipidaemia and 89.9% remission were in obstructive sleep apnoea. No patient required an emergency intervention, and there was no mortality or significant morbidity. CONCLUSIONS: This study shows acceptable results with ESG at 4 years in our unit. Regular monitoring by a multidisciplinary nurtures weight loss, resolution or improvement of comorbidities and improvement of quality of life with low perioperative complications. There is a need for more reports with this approach to determine the amount and duration of weight loss outcome and medical intervention. Wolters Kluwer - Medknow 2023 2022-08-22 /pmc/articles/PMC10034804/ /pubmed/36124467 http://dx.doi.org/10.4103/jmas.jmas_3_22 Text en Copyright: © 2022 Journal of Minimal Access Surgery https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Bhandari, Mahak
Kosta, Susmit
Reddy, Manoj
Mathur, Winni
Neto, Manoel Galvao
Bhandari, Mohit
Four-year outcomes for endoscopic sleeve gastroplasty from a single centre in India
title Four-year outcomes for endoscopic sleeve gastroplasty from a single centre in India
title_full Four-year outcomes for endoscopic sleeve gastroplasty from a single centre in India
title_fullStr Four-year outcomes for endoscopic sleeve gastroplasty from a single centre in India
title_full_unstemmed Four-year outcomes for endoscopic sleeve gastroplasty from a single centre in India
title_short Four-year outcomes for endoscopic sleeve gastroplasty from a single centre in India
title_sort four-year outcomes for endoscopic sleeve gastroplasty from a single centre in india
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034804/
https://www.ncbi.nlm.nih.gov/pubmed/36124467
http://dx.doi.org/10.4103/jmas.jmas_3_22
work_keys_str_mv AT bhandarimahak fouryearoutcomesforendoscopicsleevegastroplastyfromasinglecentreinindia
AT kostasusmit fouryearoutcomesforendoscopicsleevegastroplastyfromasinglecentreinindia
AT reddymanoj fouryearoutcomesforendoscopicsleevegastroplastyfromasinglecentreinindia
AT mathurwinni fouryearoutcomesforendoscopicsleevegastroplastyfromasinglecentreinindia
AT netomanoelgalvao fouryearoutcomesforendoscopicsleevegastroplastyfromasinglecentreinindia
AT bhandarimohit fouryearoutcomesforendoscopicsleevegastroplastyfromasinglecentreinindia